These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8807722)

  • 1. Defibrotide as a possible anti-ischemic drug.
    Coccheri S; Nazzari M
    Semin Thromb Hemost; 1996; 22 Suppl 1():9-14. PubMed ID: 8807722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of defibrotide in endothelial cell protection.
    Corsi M; Parise M; Gaja G; Ferrero ME
    Int J Tissue React; 1993; 15(4):157-61. PubMed ID: 8188455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defibrotide, a stimulator of prostacyclin (PGI2) production, prevents the effects of ischaemic damage.
    Ferrero ME; Marni A; Rovati M; Aimini R; Salari PC; Gaja G
    Int J Tissue React; 1989; 11(4):179-84. PubMed ID: 2517498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated view of the activities of defibrotide.
    Pescador R; Porta R; Ferro L
    Semin Thromb Hemost; 1996; 22 Suppl 1():71-5. PubMed ID: 8807733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of defibrotide on prostacyclin release from isolated rabbit kidneys and protection from post-ischemic acute renal failure in vivo.
    Berti F; Rossoni G; Bianchi G; Alberico P; Tettamanti R; Calvani AB; Mantovani M; Prino G
    Eicosanoids; 1991; 4(4):209-15. PubMed ID: 1789997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury.
    Hohlfeld T; Strobach H; Schrör K
    J Pharmacol Exp Ther; 1993 Jan; 264(1):397-405. PubMed ID: 8423539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology and mode of action of a new antithrombotic compound: Defibrotide.
    Ulutin ON; Cizmeci G; Balkuv-Ulutin S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):177-80. PubMed ID: 2459016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defibrotide protects rabbit myocardium from ischemia: relationship with the eicosanoid system.
    Berti F; Rossini G; Omini C; Daffonchio L; Tondo C; Cali G
    Pol J Pharmacol Pharm; 1987; 39(5):657-65. PubMed ID: 3506734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of arachidonate metabolite generation in human blood by oral defibrotide.
    Biagi G; Legnani C; Rodorigo G; Coccheri S
    Arzneimittelforschung; 1991 May; 41(5):511-4. PubMed ID: 1654908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defibrotide reduces monocyte PAI-2 and procoagulant activity.
    Abbate R; Gori AM; Martini F; Attanasio M; Comeglio P; Giusti B; Zarone N; Francalanci I; Prisco D; Gensini GF
    Semin Thromb Hemost; 1995; 21(2):245-50. PubMed ID: 7660147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of defibrotide on platelet function.
    Ulutin ON; Balkuv-Ulutin S; Bezer-Göker B; Cizmeci G; Ferhanoğlu B; Ozsoy Y; Uğur MS; Ulutin T; Yaman A; Yardimci T
    Semin Thromb Hemost; 1996; 22 Suppl 1():21-4. PubMed ID: 8807724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology and clinical pharmacology of defibrotide: a new profibrinolytic, antithrombotic and anti-platelet substance.
    Ulutin ON; Balkuv-Ulutin S; Ugur MS; Ulutin T; Ozsoy Y; Cizmeci G
    Adv Exp Med Biol; 1990; 281():429-38. PubMed ID: 2102624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials with defibrotide in vascular disorders.
    Cimminiello C
    Semin Thromb Hemost; 1996; 22 Suppl 1():29-34. PubMed ID: 8807726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of defibrotide against myocardial ischemia and decline of beta-adrenoceptor function in the rabbit.
    Berti F; Rossoni G; Niada R; Omini C; Pretolani M; Mandelli C
    Haemostasis; 1986; 16 Suppl 1():13-7. PubMed ID: 3011616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the use of defibrotide.
    Guglielmelli T; Bringhen S; Palumbo A
    Expert Opin Biol Ther; 2012 Mar; 12(3):353-61. PubMed ID: 22283742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heart.
    Berti F; Rossoni G; Omini C; Folco G; Daffonchio L; Viganó T; Tondo C
    Eur J Pharmacol; 1987 Mar; 135(3):375-82. PubMed ID: 3556200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of venous endothelial activity and transcellular calcium transport by defibrotide: the adenosine hypothesis.
    Pasini FL; Frigerio C; Capecchi PL; Ceccatelli L; Messa GL; Franchi M; Di Perri T
    Semin Thromb Hemost; 1996; 22 Suppl 1():15-20. PubMed ID: 8807723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage.
    Thiemermann C; Löbel P; Schrör K
    Am J Cardiol; 1985 Dec; 56(15):978-82. PubMed ID: 3907318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man.
    Coccheri S; Biagi G; Legnani C; Bianchini B; Grauso F
    Eur J Clin Pharmacol; 1988; 35(2):151-6. PubMed ID: 3191933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of impaired liver metabolism due to ischemia in rats. Efficacy of defibrotide administration.
    Ferrero ME; Marni A; Gaja G
    J Hepatol; 1990 Mar; 10(2):223-7. PubMed ID: 2332594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.